These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 454528)

  • 21. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
    Davidoff F
    R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
    Sánchez-Casals MS; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
    [No Abstract]   [Full Text] [Related]  

  • 30. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
    Matuszek M; Gagało I; Hać E
    Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral hypoglycemic agents and heart.
    Manoria P; Manoria P
    Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness, toxicity and action of new hypoglycemic agents].
    Wójcikowski C
    Pol Tyg Lek; 1978 Oct; 33(40):1583-4. PubMed ID: 704465
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sulfonylureas and diabetes mellitus].
    Ascaso JF
    Med Clin (Barc); 1983 Sep; 81(7):302-4. PubMed ID: 6645672
    [No Abstract]   [Full Text] [Related]  

  • 37. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by glypentide and other oral antidiabetic agents (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):277-81. PubMed ID: 4376253
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.